
Tuesday, December 10, 2019 11:00:20 PM
NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that it will host a NASH Commercial Da...
Got this from ICPT - Intercept to Host NASH Commercial Day for Investors on December 16, 2019 in New York

Liked By
Spread the love. Be the first to like this post!
Recent ICPT News
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/16/2023 08:08:17 PM
- Intercept Says FDA Sets AdCom Meeting on Obeticholic Acid • Dow Jones News • 03/10/2023 03:05:00 PM
- Intercept Announces FDA Advisory Committee Meeting Date for Obeticholic Acid as a Treatment for Pre-Cirrhotic Liver Fibrosis due to NASH • GlobeNewswire Inc. • 03/10/2023 02:05:00 PM
- Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Barclays Global Healthcare Conference March 14, 2023 • GlobeNewswire Inc. • 03/09/2023 01:00:00 PM
- Annual Report (10-k) • Edgar (US Regulatory) • 03/02/2023 09:33:43 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/02/2023 12:06:06 PM
- Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates; Issues 2023 Financial Guidance • GlobeNewswire Inc. • 03/02/2023 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/27/2023 01:01:09 PM
- Intercept Pharmaceuticals to Participate in Cowen’s 43rd Annual Health Care Conference on March 7, 2023 • GlobeNewswire Inc. • 02/27/2023 01:00:00 PM
- Intercept to Announce Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023 • GlobeNewswire Inc. • 02/23/2023 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/21/2023 01:01:29 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/16/2023 09:03:54 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 09:03:34 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 04:49:43 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/03/2023 09:02:33 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/02/2023 05:26:01 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:05:33 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:05:13 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:04:43 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:04:15 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 01/31/2023 06:59:42 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/25/2023 01:01:38 PM
- FDA Accepts Intercept’s New Drug Application for OCA for the Treatment of Pre-Cirrhotic Liver Fibrosis Due to NASH • GlobeNewswire Inc. • 01/19/2023 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/17/2023 01:01:39 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/11/2023 01:01:54 PM
Hollywall Entertainment, Inc. (HWAL) forms new Technology Division • HWAL • Mar 20, 2023 12:50 PM
Thunder Energies Retains Global IR Firm • TNRG • Mar 20, 2023 9:30 AM
Tudor Gold Announces Significant Upgrade to Mineral Resource Estimate for the Goldstorm Porphyry Deposit..... • TUD • Mar 16, 2023 11:56 AM
Golden Matrix Reports First Quarter Financial Results With Record Revenues of $10.78 Million • GMGI • Mar 16, 2023 9:24 AM
Swifty Global Releases Details of Its Annual Shareholder Meeting • DRCR • Mar 16, 2023 9:18 AM
Authentic Holdings, Inc., to Acquire Maybacks Global Entertainment LLC • AHRO • Mar 16, 2023 8:00 AM